Want to cut your energy bills? Here’s how five experts are doing it 
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks 
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver 
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus 
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow 
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges 
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO 
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions 
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO 
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns 
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal 
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs 
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank 
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic 
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe 
MIGDAL HA'EMEQ, Israel, May 25, 2017 -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today announced that Mr. Erez Israeli, the Company’s Chief Executive Officer, will present at the Jefferies 2017 Global Healthcare Conference being held on June 6-9, 2017 at the Grand Hyatt New York in New York City.
Mr. Israeli is scheduled to present on Thursday, June 8, 2017 at 4:30 PM EDT. The presentation will take place in 7 Imperial. The presentation will be followed immediately by a breakout session at 5:00 PM EDT in the Booth Room.
Mr. Israeli and Mr. Oren Bryan, the Company’s Chief Financial Officer, will also be available to participate in one-to-one meetings with investors during the conference.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies.
Contact The Ruth Group Tram Bui / Alexander Lobo Phone: 646-536-7035 / 7037 [email protected] [email protected]
